Relevance to NICE guidance programmes

Relevance to NICE guidance programmes

Depot medroxyprogesterone acetate for subcutaneous administration (DMPA‑SC) has not yet been considered through the topic selection process for NICE technology appraisals, and is not currently planned into any other work programme.